Abstract
Research on the human gut pathogen Clostridium difficile and its toxins has gained much attention, particularly as a consequence of the increasing threat to human health presented by emerging hypervirulent strains. Toxin A (TcdA) and B (TcdB) are the two major virulence determinants of C. difficile. Both are single-chain proteins with a similar multidomain architecture. Certain hypervirulent C. difficile strains also produce a third toxin, namely binary toxin CDT (Clostridium difficile transferase). As C. difficile toxins are the causative agents of C. difficile-associated diseases (CDAD), such as antibiotics-associated diarrhea and pseudomembranous colitis, considerable efforts have been expended to unravel their molecular mode-of-action and the cellular mechanisms responsible for their uptake. Notably, a high proportion of studies on C. difficile toxins were performed in European laboratories. In this chapter we will highlight important recent advances in C. difficile toxins research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aktories K (2011) Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol 9:487–498
Aktories K, Wegner A (1989) ADP-ribosylation of actin by clostridial toxins. J Cell Biol 109:1385–1387
Aktories K, Bärmann M, Ohishi I, Tsuyama S, Jakobs KH, Habermann E (1986) Botulinum C2 toxin ADP-ribosylates actin. Nature 322:390–392
Aktories K, Schwan C, Jank T (2017) Clostridium difficile toxin biology. Annu Rev Microbiol 71:281–307
Albesa-Jove D, Bertrand T, Carpenter EP, Swain GV, Lim J, Zhang J et al (2010) Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS. J Mol Biol 396:1260–1270
Alvin JW, Lacy DB (2017) Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue. J Struct Biol 198:203–209
Amimoto K, Noro T, Oishi E, Shimizu M (2007) A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C. Microbiology 153:1198–1206
Barroso LA, Moncrief JS, Lyerly DM, Wilkins TD (1994) Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity. Microb Pathog 16:297–303
Barth H, Pfeifer G, Hofmann F, Maier E, Benz R, Aktories K (2001) Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J Biol Chem 276:10670–10676
Barth H, Aktories K, Popoff MR, Stiles BG (2004) Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev 68:373–402
Belyi Y, Niggeweg R, Opitz B, Vogelsgesang M, Hippenstiel S, Wilm M, Aktories K (2006) Legionella pneumophila glucosyltransferase inhibits host elongation factor 1A. Proc Natl Acad Sci U S A 103:16953–16958
Bishop AL, Hall A (2000) Rho GTPases and their effector proteins. Biochem J 348:241–255
Blonder J, Hale ML, Chan KC, Yu LR, Lucas DA, Conrads TP et al (2005) Quantitative profiling of the detergent-resistant membrane proteome of iota-b toxin induced vero cells. J Proteome Res 4:523–531
Brito GAC, Fujji J, Carneiro-Filho BA, Lima AAM, Obrig T, Guerrant RL (2002) Mechanism of Clostridium difficile toxin A – induced apoptosis in T84 cells. J Infect Dis 186:1438–1447
Burridge K, Wennerberg K (2004) Rho and Rac take center stage. Cell 116:167–179
Busch C, Hofmann F, Selzer J, Munro J, Jeckel D, Aktories K (1998) A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins. J Biol Chem 273:19566–19572
Busch C, Hofmann F, Gerhard R, Aktories K (2000) Involvement of a conserved tryptophan residue in the UDP-glucose binding of large clostridial cytotoxin glycosyltransferases. J Biol Chem 275:13228–13234
Chandrasekaran R, Kenworthy AK, Lacy DB (2016) Clostridium difficile toxin A undergoes clathrin-independent, PACSIN2-dependent endocytosis. PLoS Pathog 12:e1006070
Cherfils J, Zeghouf M (2013) Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev 93:269–309
Chumbler NM, Rutherford SA, Zhang Z, Farrow MA, Lisher JP, Farquhar E et al (2016) Crystal structure of Clostridium difficile toxin A. Nat Microbiol 1:15002
Collery MM, Kuehne SA, McBride SM, Kelly ML, Monot M, Cockayne A et al (2017) What’s a SNP between friends: the influence of single nucleotide polymorphisms on virulence and phenotypes of Clostridium difficile strain 630 and derivatives. Virulence 8:767–781
Considine RV, Simpson LL (1991) Cellular and molecular actions of binary toxins possessing ADP-ribosyltransferase activity. Toxicon 29:913–936
Cowardin CA, Buonomo EL, Saleh MM, Wilson MG, Burgess SL, Kuehne SA et al (2016) The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia. Nat Microbiol 1:16108
Czulkies BA, Mastroianni J, Lutz L, Lang S, Schwan C, Schmidt G et al (2017) Loss of LSR affects epithelial barrier integrity and tumor xenograft growth of CaCo-2 cells. Oncotarget 8:37009–37022
D’Urzo N, Malito E, Biancucci M, Bottomley MJ, Maione D, Scarselli M, Martinelli M (2012) The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release. FEBS J 279:3085–3097
Dingle T, Wee S, Mulvey GL, Greco A, Kitova EN, Sun J et al (2008) Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Glycobiology 18:698–706
Dominguez R, Holmes KC (2011) Actin structure and function. Annu Rev Biophys 40:169–186
Donald RG, Flint M, Kalyan N, Johnson E, Witko SE, Kotash C et al (2013) A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile. Microbiology 159:1254–1266
Dove CH, Wang SZ, Price SB, Phelps CJ, Lyerly DM, Wilkins TD, Johnson JL (1990) Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 58:480–488
Drabek K, van HM, Stepanova T, Draegestein K, van HR, Sayas CL et al (2006) Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. Curr Biol 16:2259–2264
Egerer M, Giesemann T, Jank T, Satchell KJ, Aktories K (2007) Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on a cysteine protease activity. J Biol Chem 282:25314–25321
Egerer M, Giesemann T, Herrmann C, Aktories K (2009) Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate. J Biol Chem 284:3389–3395
Ernst K, Langer S, Kaiser E, Osseforth C, Michaelis J, Popoff MR et al (2015) Cyclophilin-facilitated membrane translocation as pharmacological target to prevent intoxication of mammalian cells by binary clostridial actin ADP-ribosylated toxins. J Mol Biol 427:1224–1238
Ernst K, Schnell L, Barth H (2016) Host cell chaperones Hsp70/Hsp90 and peptidyl-prolyl cis/trans isomerases are required for the membrane translocation of bacterial ADP-ribosylating toxins. Curr Top Microbiol Immunol. May 20. [Epub ahead of print]
Ernst K, Schmid J, Beck M, Hagele M, Hohwieler M, Hauff P et al (2017) Hsp70 facilitates trans-membrane transport of bacterial ADP-ribosylating toxins into the cytosol of mammalian cells. Sci Rep 7:2724
Farrow MA, Chumbler NM, Lapierre LA, Franklin JL, Rutherford SA, Goldenring JR, Lacy DB (2013) Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex. Proc Natl Acad Sci U S A 110:18674–18679
Fiorentini C, Thelestam M (1991) Clostridium difficile toxin A and its effects on cells. Toxicon 29:543–567
Fiorentini C, Fabbri A, Falzano L, Fattorossi A, Matarrese P, Rivabene R, Donelli G (1998) Clostridium difficile toxin B induces apoptosis in intestinal cultured cells. Infect Immun 66:2660–2665
Frey SM, Wilkins TD (1992) Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect Immun 60:2488–2492
Frisch C, Gerhard R, Aktories K, Hofmann F, Just I (2003) The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis. Biochem Biophys Res Commun 300:706–711
Furuse M, Oda Y, Higashi T, Iwamoto N, Masuda S (2012) Lipolysis-stimulated lipoprotein receptor: a novel membrane protein of tricellular tight junctions. Ann N Y Acad Sci 1257:54–58
Gao W, Yang J, Liu W, Wang Y, Shao F (2016) Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation. Proc Natl Acad Sci U S A 113:E4857–E4866
Garcia-Mata R, Burridge K (2007) Catching a GEF by its tail. Trends Cell Biol 17:36–43
Geissler B, Tungekar R, Satchell KJ (2010) Identification of a conserved membrane localization domain within numerous large bacterial protein toxins. Proc Natl Acad Sci U S A 107:5581–5586
Genisyuerek S, Papatheodorou P, Guttenberg G, Schubert R, Benz R, Aktories K (2011) Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B. Mol Microbiol 79:1643–1654
Genth H, Aktories K, Just I (1999) Monoglucosylation of RhoA at threonine-37 blocks cytosol-membrane cycling. J Biol Chem 274:29050–29056
Gerding DN, Johnson S, Rupnik M, Aktories K (2014) Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes 5:15–27
Gerhard R (2016) Receptors and binding structures for Clostridium difficile toxins A and B. Curr Top Microbiol Immunol. [Epub ahead of print]
Gerhard R, Nottrott S, Schoentaube J, Tatge H, Olling A, Just I (2008) Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. J Med Microbiol 57:765–770
Gerhard R, Frenzel E, Goy S, Olling A (2013) Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain. J Med Microbiol 62:1414–1422
Geyer M, Wilde C, Selzer J, Aktories K, Kalbitzer HR (2003) Glucosylation of Ras by Clostridium sordellii lethal toxin: consequences for the effector loop conformations observed by NMR spectroscopy. Biochemistry 42:11951–11959
Gibert M, Monier MN, Ruez R, Hale ML, Stiles BG, Benmerah A et al (2011) Endocytosis and toxicity of clostridial binary toxins depend on a clathrin-independent pathway regulated by Rho-GDI. Cell Microbiol 13:154–170
Giesemann T, Jank T, Gerhard R, Maier E, Just I, Benz R, Aktories K (2006) Cholesterol-dependent pore formation of Clostridium difficile toxin A. J Biol Chem 281:10808–10815
Greco A, Ho JG, Lin SJ, Palcic MM, Rupnik M, Ng KK (2006) Carbohydrate recognition by Clostridium difficile toxin A. Nat Struct Mol Biol 13:460–461
Guttenberg G, Hornei S, Jank T, Schwan C, Lu W, Einsle O et al (2012) Molecular characteristics of Clostridium perfringens TpeL toxin and consequences of mono-O-GlcNAcylation of Ras in living cells. J Biol Chem 287:24929–24940
Halabi-Cabezon I, Huelsenbeck J, May M, Ladwein M, Rottner K, Just I, Genth H (2008) Prevention of the cytopathic effect induced by Clostridium difficile toxin B by active Rac1. FEBS Lett 582:3751–3756
Hale ML, Marvaud JC, Popoff MR, Stiles BG (2004) Detergent-resistant membrane microdomains facilitate Ib oligomer formation and biological activity of Clostridium perfringens iota-toxin. Infect Immun 72:2186–2193
Han S, Craig JA, Putnam CD, Carozzi NB, Tainer JA (1999) Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex. Nat Struct Biol 6:932–936
Hecht G, Pothoulakis C, LaMont JT, Madara JL (1988) Clostridium difficile toxin A pertubs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 82:1516–1524
Hecht G, Koutsouris A, Pothoulakis C, LaMont JT, Madara JL (1992) Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 102:416–423
Heine K, Pust S, Enzenmuller S, Barth H (2008) ADP-ribosylation of actin by the Clostridium botulinum C2 toxin in mammalian cells results in delayed caspase-dependent apoptotic cell death. Infect Immun 76:4600–4608
Hemmasi S, Czulkies BA, Schorch B, Veit A, Aktories K, Papatheodorou P (2015) Interaction of the Clostridium difficile binary toxin CDT and its host cell receptor, lipolysis-stimulated lipoprotein receptor (LSR). J Biol Chem 290:14031–14044
Hirase T, Kawashima S, Wong EY, Ueyama T, Rikitake Y, Tsukita S et al (2001) Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J Biol Chem 276:10423–10431
Ho JG, Greco A, Rupnik M, Ng KK (2005) Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc Natl Acad Sci U S A 102:18373–18378
Hofmann F, Busch C, Prepens U, Just I, Aktories K (1997) Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J Biol Chem 272:11074–11078
Hofmann F, Busch C, Aktories K (1998) Chimeric clostridial cytotoxins: identification of the N-terminal region involved in protein substrate recognition. Infect Immun 66:1076–1081
Holmes KC, Popp D, Gebhard W, Kabsch W (1990) Atomic model of the actin filament. Nature 347:44–49
Ishida Y, Maegawa T, Kondo T, Kimura A, Iwakura Y, Nakamura S, Mukaida N (2004) Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis. J Immunol 172:3018–3025
Jafari NV, Kuehne SA, Bryant CE, Elawad M, Wren BW, Minton NP et al (2013) Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s). PLoS One 8:e69846
Jaffe AB, Hall A (2005) Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21:247–269
Jank T, Aktories K (2008) Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol 16:222–229
Jank T, Reinert DJ, Giesemann T, Schulz GE, Aktories K (2005) Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis. J Biol Chem 280:37833–37838
Jank T, Giesemann T, Aktories K (2007) Clostridium difficile glucosyltransferase toxin B – essential amino acids for substrate-binding. J Biol Chem 282:35222–35231
Jank T, Bogdanovic X, Wirth C, Haaf E, Spoerner M, Bohmer KE et al (2013) A bacterial toxin catalyzing tyrosine glycosylation of Rho and deamidation of Gq and Gi proteins. Nat Struct Mol Biol 20:1273–1280
Jank T, Belyi Y, Aktories K (2015a) Bacterial glycosyltransferase toxins. Cell Microbiol 17:1752–1765
Jank T, Eckerle S, Steinemann M, Trillhaase C, Schimpl M, Wiese S et al (2015b) Tyrosine glycosylation of Rho by Yersinia toxin impairs blastomere cell behaviour in zebrafish embryos. Nat Commun 6:7807
Jorgensen I, Miao EA (2015) Pyroptotic cell death defends against intracellular pathogens. Immunol Rev 265:130–142
Just I, Gerhard R (2004) Large clostridial cytotoxins. Rev Physiol Biochem Pharmacol 152:23–47
Just I, Selzer J, Wilm M, Von Eichel-Streiber C, Mann M, Aktories K (1995a) Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375:500–503
Just I, Wilm M, Selzer J, Rex G, Von Eichel-Streiber C, Mann M, Aktories K (1995b) The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 270:13932–13936
Just I, Selzer J, Hofmann F, Green GA, Aktories K (1996) Inactivation of Ras by Clostridium sordellii lethal toxin-catalyzed glucosylation. J Biol Chem 271:10149–10153
Kaiser E, Kroll C, Ernst K, Schwan C, Popoff M, Fischer G et al (2011) Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90. Infect Immun 79:3913–3921
Kim J, Pai H, Seo MR, Kang JO (2012) Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections. BMC Infect Dis 12:109
Kodama A, Karakesisoglou I, Wong E, Vaezi A, Fuchs E (2003) ACF7: an essential integrator of microtubule dynamics. Cell 115:343–354
Krivan HC, Clark GF, Smith DF, Wilkins TD (1986) Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun 53:573–581
Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP (2010) The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711–713
Kuehne SA, Collery MM, Kelly ML, Cartman ST, Cockayne A, Minton NP (2014) Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J Infect Dis 209:83–86
Kushnaryov VM, Sedmark JJ (1989) Effect of Clostridium difficile enterotoxin A on ultrastructure of chinese hamster ovary cells. Infect Immun 57(12):3914–3921
La France ME, Farrow MA, Chandrasekaran R, Sheng JS, Rubin DH, Lacy DB (2015) Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity. Proc Natl Acad Sci U S A 112:7073–7078
Lamaze C, Dujeancourt A, Baba T, Lo CG, Benmerah A, Dautry-Varsat A (2001) Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol Cell 7:661–671
Lambert GS, Baldwin MR (2016) Evidence for dual receptor-binding sites in Clostridium difficile toxin A. FEBS Lett 590:4550–4563
Lemichez E, Aktories K (2013) Hijacking of Rho GTPases during bacterial infection. Exp Cell Res 319:2329–2336
Li S, Zhang L, Yao Q, Li L, Dong N, Rong J et al (2013) Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature 501:242–246
Linevsky JK, Pothoulakis C, Keates S, Warny M, Keates AC, LaMont JT, Kelly CP (1997) IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes. Am J Phys 273:G1333–G1340
Lu A, Wu H (2015) Structural mechanisms of inflammasome assembly. FEBS J 282:435–444
Lyerly DM, Krivan HC, Wilkins TD (1988) Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1:1–18
Lyerly DM, Barroso LA, Wilkins TD, Depitre C, Corthier G (1992) Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 60:4633–4639
Lyras D, O’Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T et al (2009) Toxin B is essential for virulence of Clostridium difficile. Nature 458:1176–1179
Mahida YR, Makh S, Hyde S, Gray T, Borriello SP (1996) Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 38:337–347
Manse JS, Baldwin MR (2015) Binding and entry of Clostridium difficile toxin B is mediated by multiple domains. FEBS Lett 589:3945–3951
Margarit SM, Davidson W, Frego L, Stebbins CE (2006) A steric antagonism of actin polymerization by a salmonella virulence protein. Structure 14:1219–1229
Masuda S, Oda Y, Sasaki H, Ikenouchi J, Higashi T, Akashi M et al (2011) LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci 124:548–555
Mesli S, Javorschi S, Berard AM, Landry M, Priddle H, Kivlichan D et al (2004) Distribution of the lipolysis stimulated receptor in adult and embryonic murine tissues and lethality of LSR−/− embryos at 12.5 to 14.5 days of gestation. Eur J Biochem 271:3103–3114
Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A et al (2010) Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11:1136–1142
Monot M, Eckert C, Lemire A, Hamiot A, Dubois T, Tessier C et al (2015) Clostridium difficile: new insights into the evolution of the pathogenicity locus. Sci Rep 5:15023
Mostowy S, Cossart P (2012) Septins: the fourth component of the cytoskeleton. Nat Rev Mol Cell Biol 13:183–194
Nagahama M, Yamaguchi A, Hagiyama T, Ohkubo N, Kobayashi K, Sakurai J (2004) Binding and internalization of Clostridium perfringens iota-toxin in lipid rafts. Infect Immun 72:3267–3275
Nagahama M, Ohkubo A, Oda M, Kobayashi K, Amimoto K, Miyamoto K, Sakurai J (2011) Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins. Infect Immun 79:905–910
Ng J, Hirota SA, Gross O, Li Y, Ulke-Lemee A, Potentier MS et al (2010) Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology 139:542–552
Nobes C, Hall A (1994) Regulation and function of the Rho subfamily of small GTPases. Curr Opin Genet Dev 4:77–81
Nolke T, Schwan C, Lehmann F, Ostevold K, Pertz O, Aktories K (2016) Septins guide microtubule protrusions induced by actin-depolymerizing toxins like Clostridium difficile transferase (CDT). Proc Natl Acad Sci U S A 113:7870–7875
Nusrat A, Giry M, Turner JR, Colgan SP, Parkos CA, Carnes D et al (1995) Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc Natl Acad Sci U S A 92:10629–10633
Nusrat A, Von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, Parkos CA (2001) Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun 69:1329–1336
Olling A, Goy S, Hoffmann F, Tatge H, Just I, Gerhard R (2011) The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A. PLoS One 6:e17623
Orth P, Xiao L, Hernandez LD, Reichert P, Sheth PR, Beaumont M et al (2014) Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography. J Biol Chem 289:18008–18021
Ottlinger ME, Lin S (1988) Clostridium difficile toxin B induces reorganization of actin, vinculin, and talin in cultures cells. Exp Cell Res 174:215–229
Papatheodorou P, Aktories K (2016) Receptor-binding and uptake of binary actin-ADP-ribosylating toxins. Curr Top Microbiol Immunol. Nov 6. [Epub ahead of print]
Papatheodorou P, Zamboglou C, Genisyuerek S, Guttenberg G, Aktories K (2010) Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis. PLoS One 5:e10673
Papatheodorou P, Carette JE, Bell GW, Schwan C, Guttenberg G, Brummelkamp TR, Aktories K (2011) Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT). Proc Natl Acad Sci U S A 108:16422–16427
Papatheodorou P, Wilczek C, Nolke T, Guttenberg G, Hornuss D, Schwan C, Aktories K (2012) Identification of the cellular receptor of Clostridium spiroforme toxin. Infect Immun 80:1418–1423
Papatheodorou P, Hornuss D, Nolke T, Hemmasi S, Castonguay J, Picchianti M, Aktories K (2013) Clostridium difficile binary toxin CDT induces clustering of the lipolysis-stimulated lipoprotein receptor into lipid rafts. MBio 4:e00244–e00213
Park YH, Wood G, Kastner DL, Chae JJ (2016) Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol 17:914–921
Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR (1997) Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 65:1402–1407
Perieteanu AA, Visschedyk DD, Merrill AR, Dawson JF (2010) ADP-ribosylation of cross-linked actin generates barbed-end polymerization-deficient F-actin oligomers. Biochemistry 49:8944–8954
Petosa C, Collier RJ, Klimpel KR, Leppla SH, Liddingtom RC (1997) Crystal structure of the anthrax toxin protective antigen. Nature 385:833–838
Pfeifer G, Schirmer J, Leemhuis J, Busch C, Meyer DK, Aktories K, Barth H (2003) Cellular uptake of Clostridium difficile toxin B: translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells. J Biol Chem 278:44535–44541
Popoff MR, Boquet P (1988) Clostridium spiroforme toxin is a binary toxin which ADP- ribosylates cellular actin. Biochem Biophys Res Commun 152:1361–1368
Pruitt RN, Chagot B, Cover M, Chazin WJ, Spiller B, Lacy DB (2009) Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A. J Biol Chem 284:21934–21940
Pruitt RN, Chambers MG, Ng KK, Ohi MD, Lacy DB (2010) Structural organization of the functional domains of Clostridium difficile toxins A and B. Proc Natl Acad Sci U S A 107:13467–13472
Pruitt RN, Chumbler NM, Rutherford SA, Farrow MA, Friedman DB, Spiller B, Lacy DB (2012) Structural determinants of Clostridium difficile toxin A glucosyltransferase activity. J Biol Chem 287:8013–8020
Puri AW, Lupardus PJ, Deu E, Albrow VE, Garcia KC, Bogyo M, Shen A (2010) Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB. Chem Biol 17:1201–1211
Qa’Dan M, Spyres LM, Ballard JD (2000) pH-induced conformational changes in Clostridium difficile toxin B. Infect Immun 68:2470–2474
Qa’Dan M, Spyres LM, Ballard JD (2001) pH-enhanced cytopathic effects of Clostridium sordellii lethal toxin. Infect Immun 69:5487–5493
Qa’Dan M, Christensen KA, Zhang L, Roberts TM, Collier RJ (2005) Membrane insertion by anthrax protective antigen in cultured cells. Mol Cell Biol 25:5492–5498
Qiu B, Pothoulakis C, Castagliuolo I, Nikulasson S, La Mont JT (1999) Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats. Am J Phys 276:G485–G490
Reineke J, Tenzer S, Rupnik M, Koschinski A, Hasselmayer O, Schrattenholz A et al (2007) Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446:415–419
Reinert DJ, Jank T, Aktories K, Schulz GE (2005) Structural basis for the function of Clostridium difficile toxin B. J Mol Biol 351:973–981
Roeder M, Nestorovich EM, Karginov VA, Schwan C, Aktories K, Barth H (2014) Tailored cyclodextrin pore blocker protects mammalian cells from Clostridium difficile binary toxin CDT. Toxins (Basel) 6:2097–2114
Roth BM, Godoy-Ruiz R, Varney KM, Rustandi RR, Weber DJ (2016a) 1H, 13C, and 15N resonance assignments of an enzymatically active domain from the catalytic component (CDTa, residues 216-420) of a binary toxin from Clostridium difficile. Biomol NMR Assign 10:213–217
Roth BM, Varney KM, Rustandi RR, Weber DJ (2016b) (1)H(N), (13)C, and (15)N resonance assignments of the CDTb-interacting domain (CDTaBID) from the Clostridium difficile binary toxin catalytic component (CDTa, residues 1–221). Biomol NMR Assign 10:335–339
Rupnik M, Janezic S (2016) An update on Clostridium difficile toxinotyping. J Clin Microbiol 54:13–18
Rupnik M, Avesani V, Janc M, Von Eichel-Streiber C, Delmée M (1998) A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36:2240–2247
Rupnik M, Pabst S, Rupnik M, Von Eichel-Streiber C, Urlaub H, Soling HD (2005) Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 151:199–208
Russo HM, Rathkey J, Boyd-Tressler A, Katsnelson MA, Abbott DW, Dubyak GR (2016) Active caspase-1 induces plasma membrane pores that precede pyroptotic lysis and are blocked by lanthanides. J Immunol 197:1353–1367
Sauerborn M, Leukel P, Von Eichel-Streiber C (1997) The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality. FEMS Microbiol Lett 155:45–54
Schering B, Bärmann M, Chhatwal GS, Geipel U, Aktories K (1988) ADP-ribosylation of skeletal muscle and non- muscle actin by Clostridium perfringens iota toxin. Eur J Biochem 171:225–229
Schleberger C, Hochmann H, Barth H, Aktories K, Schulz GE (2006) Structure and action of the binary C2 toxin from Clostridium botulinum. J Mol Biol 364:705–715
Schorch B, Song S, van Diemen FR, Bock HH, May P, Herz J et al (2014) LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins. Proc Natl Acad Sci U S A 111:6431–6436
Schwan C, Stecher B, Tzivelekidis T, Van HM, Rohde M, Hardt WD et al (2009) Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog 5:e1000626
Schwan C, Kruppke AS, Nolke T, Schumacher L, Koch-Nolte F, Kudryashev M et al (2014) Clostridium difficile toxin CDT hijacks microtubule organization and reroutes vesicle traffic to increase pathogen adherence. Proc Natl Acad Sci U S A 111:2313–2318
Sehr P, Joseph G, Genth H, Just I, Pick E, Aktories K (1998) Glucosylation and ADP-ribosylation of Rho proteins – effects on nucleotide binding, GTPase activity, and effector-coupling. Biochemistry 37:5296–5304
Selzer J, Hofmann F, Rex G, Wilm M, Mann M, Just I, Aktories K (1996) Clostridium novyi alpha-toxin-catalyzed incorporation of GlcNAc into Rho subfamily proteins. J Biol Chem 271:25173–25177
Shen A, Lupardus PJ, Gersch MM, Puri AW, Albrow VE, Garcia KC, Bogyo M (2011) Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins. Nat Struct Mol Biol 18:364–371
Sohet F, Lin C, Munji RN, Lee SY, Ruderisch N, Soung A et al (2015) LSR/angulin-1 is a tricellular tight junction protein involved in blood-brain barrier formation. J Cell Biol 208:703–711
Steiner TS, Flores CA, Pizarro TT, Guerrant RL (1997) Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol 4:719–722
Stiles BG, Hale ML, Marvaud J-C, Popoff M (2000) Clostridium perfringens iota toxin: binding studies and characterization of cell surface receptor by fluorescence-activated cytometry. Infect Immun 68:3475–3484
Tao L, Zhang J, Meraner P, Tovaglieri A, Wu X, Gerhard R et al (2016) Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. Nature 538:350–355
Tcherkezian J, Lamarche-Vane N (2007) Current knowledge of the large RhoGAP family of proteins. Biol Cell 99:67–86
Tsuge H, Nagahama M, Oda M, Iwamoto S, Utsunomiya H, Marquez VE et al (2008) Structural basis of actin recognition and arginine ADP-ribosylation by Clostridium perfringens iota-toxin. Proc Natl Acad Sci U S A 105:7399–7404
Tsurumura T, Tsumori Y, Qiu H, Oda M, Sakurai J, Nagahama M, Tsuge H (2013) Arginine ADP-ribosylation mechanism based on structural snapshots of iota-toxin and actin complex. Proc Natl Acad Sci U S A 110:4267–4272
Tucker KD, Wilkins TD (1991) Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect Immun 59:73–78
Vandekerckhove J, Schering B, Bärmann M, Aktories K (1987) Clostridium perfringens iota toxin ADP-ribosylates skeletal muscle actin in Arg-177. FEBS Lett 225:48–52
Vandekerckhove J, Schering B, Bärmann M, Aktories K (1988) Botulinum C2 toxin ADP-ribosylates cytoplasmic b/g-actin in arginine 177. J Biol Chem 263:696–700
Vetter IR, Hofmann F, Wohlgemuth S, Herrmann C, Just I (2000) Structural consequences of mono-glucosylation of Ha-Ras by Clostridium sordellii lethal toxin. J Mol Biol 301:1091–1095
Von Eichel-Streiber C, Sauerborn M (1990) Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. Gene 96:107–113
Von Eichel-Streiber C, Laufenberg-Feldmann R, Sartingen S, Schulze J, Sauerborn M (1992a) Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet 233:260–268
Von Eichel-Streiber C, Sauerborn M, Kuramitsu HK (1992b) Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases. J Bacteriol 174:6707–6710
Voth DE, Ballard JD (2005) Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18:247–263
Warny M, Keates AC, Keates S, Castagliuolo I, Zacks JK, Aboudola S et al (2000) p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest 105:1147–1156
Wegner A, Aktories K (1988) ADP-ribosylated actin caps the barbed ends of actin filaments. J Biol Chem 263:13739–13742
Weigt C, Just I, Wegner A, Aktories K (1989) Nonmuscle actin ADP-ribosylated by botulinum C2 toxin caps actin filaments. FEBS Lett 246:181–184
Wiegers W, Just I, Müller H, Hellwig A, Traub P, Aktories K (1991) Alteration of the cytoskeleton of mammalian cells cultured in vitro by Clostridium botulinum C2 toxin and C3 ADP-ribosyltransferase. Eur J Cell Biol 54:237–245
Wigelsworth DJ, Ruthel G, Schnell L, Herrlich P, Blonder J, Veenstra TD et al (2012) CD44 promotes intoxication by the clostridial iota-family toxins. PLoS One 7:e51356
Wille M, Just I, Wegner A, Aktories K (1992) ADP-ribosylation of the gelsolin-actin complex by clostridial toxins. J Biol Chem 267:50–55
Wohlan K, Goy S, Olling A, Srivaratharajan S, Tatge H, Genth H, Gerhard R (2014) Pyknotic cell death induced by Clostridium difficile TcdB: chromatin condensation and nuclear blister are induced independently of the glucosyltransferase activity. Cell Microbiol 16:1678–1692
Wren BW (1991) A family of clostridial and streptococcal ligand-binding proteins with conserved C-terminal repeat sequences. Mol Microbiol 5:797–803
Xu H, Yang J, Gao W, Li L, Li P, Zhang L et al (2014) Innate immune sensing of bacterial modifications of Rho GTPases by the pyrin inflammasome. Nature 513:237–241
Yen FT, Mann CJ, Guermani LM, Hannouche NF, Hubert N, Hornick CA et al (1994) Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Biochemistry 33:1172–1180
Yen FT, Masson M, Clossais-Besnard N, Andre P, Grosset JM, Bougueleret L et al (1999) Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver. J Biol Chem 274:13390–13398
Young JA, Collier RJ (2007) Anthrax toxin: receptor-binding, internalization, pore formation, and translocation. Annu Rev Biochem 76:243–265
Yuan PF, Zhang HM, Cai CZ, Zhu SY, Zhou YX, Yang XZ et al (2015) Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B. Cell Res 25:157–168
Zeiser J, Gerhard R, Just I, Pich A (2013) Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques. J Proteome Res 12:1604–1618
Zhang Z, Park M, Tam J, Auger A, Beilhartz GL, Lacy DB, Melnyk RA (2014) Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore. Proc Natl Acad Sci U S A 111:3721–3726
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Papatheodorou, P., Barth, H., Minton, N., Aktories, K. (2018). Cellular Uptake and Mode-of-Action of Clostridium difficile Toxins. In: Mastrantonio, P., Rupnik, M. (eds) Updates on Clostridium difficile in Europe. Advances in Experimental Medicine and Biology(), vol 1050. Springer, Cham. https://doi.org/10.1007/978-3-319-72799-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-72799-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72798-1
Online ISBN: 978-3-319-72799-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)